期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

诺舒阻抗控制系统治疗月经过多的临床分析 被引量：11

原文传递
导出
摘要 女性正常月经周期21～35d，经期2～7d，经量为30～50ml。通常将经量超过80ml或经期超过7d称为月经过多。功能失调性子宫出血（功血）、慢性肾功能不全、血小板减少、凝血功能障碍等均可导致月经过多，严重影响患者的生命质量。应用诺舒（NovaSure）阻抗控制系统（诺舒）行子宫内膜切除术是治疗月经过多的有效手术方式。
作者 肖松舒 蒋建发 万亚军 马洁稚 薛敏
机构地区 中南大学湘雅三医院妇产科
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2013年第5期377-378,共2页 Chinese Journal of Obstetrics and Gynecology
关键词 月经过多 系统治疗 临床分析 阻抗 功能失调性子宫出血 慢性肾功能不全 子宫内膜切除术 正常月经周期
分类号 R711 [医药卫生—妇产科学]
  • 相关文献

参考文献8

  • 1Davidson BR, Dipiero CM, Govoni KD, et al. Abnormal uterine bleeding during the reproductive years. J Midwifery Womens Health,2012, 57:248-254.
  • 2Pollock W, Jamieson W. Next-generation NovaSure device for endometrial ablation:assessing ease-of-use among physicians. Int J Womens Health ,2012,4 : 109-113.
  • 3Bongers MY. Second-generation endometrial ablation treatment: Novasure. Best Pract Res Clin Obstet Gynaecol, 2007, 21: 989- 994.
  • 4Kleijn JH, Engels R, Bourdrez P, et al. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG,2008,115 : 193-198.
  • 5李屹,贾杰,李荔,毛玲芝,孙晓峰,张舒婷,罗喜平.阻抗控制子宫内膜去除术(NovaSure)与微波子宫内膜去除术(MEA)治疗月经过多的临床观察[J].吉林医学,2012,33(19):4077-4080. 被引量：9
  • 6Fakih M, Cherfan V, Abdallah E. Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population. Int J Gynaecol Obstet,2011,113 : 120-123.
  • 7Asgari Z, Moini A, Samiee H, et al. Endometrial ablation with the NovaSure system in Iran. Int .1 Gvnaecol Obstet.2011 _ 114,73-75.
  • 8宋菁华,李斌,刘桂芝.诺舒(NovaSure)阻抗控制子宫内膜切除系统治疗异常子宫出血的临床研究[J].中国微创外科杂志,2011,11(12):1125-1127. 被引量：43

二级参考文献21

  • 1Goodman A. Abnormal genital tract bleedlng. Clin Cornerstone, 2000,3 ( 1 ) :25 - 35.
  • 2Iglesias DA, Madani SS, Davis JD. The effectiveness of endometrial ablation with the Hydro Thermablator (HTA) for abnormal uterine bleeding. Am J Obstet Gynecol, 2010,202 ( 6 ) :622.
  • 3Kalkat RK, Cartmill RS. NovaSure endometrial ablation under local anaesthesia in an outpatieat setting:An observational study. J Obstet Gynaecol,2011,31 (2) :1:52 - 155.
  • 4Gallinat A. An impedance-controlled system for endometrial ablation : five-year follow-up of 107 patients. J Reprod Med ,2007,52 (6) :467 -472.
  • 5Asgari Z, Moini A, Samiee H, et al. Endometrial ablation with the NovaSure system in Iran. In t J Gynaecol Obstet ,2011,114( 1 ):73 -75.
  • 6Elmardi A, Furara S, Khan F, et al. NovaSure impedance controlled system for endometrial ablation: the experience of the first UK reference centre. J Obstet Gynaecol,2009,29 (5) :419 - 422.
  • 7Hazard report. Incorrect measurement of uterine cavity while using Hologic NovaSure endometrial ablation system can result in patient injury. Health Devices, 2009,38 ( 9 ) : 302 - 304.
  • 8Fakih M, Cherfan V,Abdallah E, et al. Success rate, quality of life, and descriptive analysis atier generalized endometrial ablation in an obese population. Int J Gynaecol Obstet ,2011,113 ( 2 ) : 120 - 123.
  • 9冯缵冲 邵敬於主编.实用官腔镜学[M].上海：上海医科大学出版社,1999.37.
  • 10冯缵冲 邵敬於.实用官腔镜学[M].上海:上海医科大学出版社,1999.47.

共引文献47

同被引文献51

  • 1代立平.诺舒阻抗控制子宫内膜切除系统治疗功能失调性子宫出血的疗效及安全性[J].世界临床医学,2017,11(21):109-109. 被引量：1
  • 2邵敬於,冯缵冲.实用宫腔镜学[M].上海:上海医科大学出版社,1999:120.
  • 3Davidson BR,Dipiero CM,Govoni KD,et al.Abnormal uterine bleeding during the reproductive years[J].J Midwifery Women Health,2012,57(3):248-254.
  • 4Pollock W,Jamieson W.Next-generation NovaSure device for endometrial ablation:assessing ease-of-use among physicians[J].Int J Women Health,2012,4(9):109-113.
  • 5Campbell P,Monaghan C,Parker M.Novasure endometrial ablation:a review of 400 cases[J].Gynecological Surgery,2012,9(1):73-76.
  • 6Lukes AS,McBride RJ,Herring AH,et al.Improved premenstrual syndrome symptoms after Novasure endometrial ablation[J].J Minim Invasive Gynecol,2011,18(5):607-611.
  • 7Bongers MY,Bourdrez P,Mol BW,et al.Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation[J].BJOG,2004,111(10):1095-1102.
  • 8Davidson B R, Dipiero C M, Govoni K D, et al. Abnormal uterine bleeding during the reproductive years[J]. J Midwifery Womens Health,2012,57(3):248-254.
  • 9Pollock W, Jamieson W. Next-generation NovaSure device for endometrial ablation: assessing ease-of-use among physicians [J]. Int J Womens Health, 2012, 4(9): 109-113.
  • 10Campbell P, Monaghan C, Parker M. Novasure endometrial abla- tion: a review of 400 cases[J]. Gynecological Surgery, 2012, 9(1): 73-76.

引证文献11

二级引证文献41

中华妇产科杂志
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部